Suppr超能文献

甲状腺毒症性周期性瘫痪:一个凸显诊断挑战与管理的独特病例

Thyrotoxic Periodic Paralysis: A Unique Case Highlighting the Diagnostic Challenges and Management.

作者信息

Atrash Jawad, Musleh Tariq, Naji Yazan, Said Vida, Saraheen Monjed

机构信息

Internal Medicine Department, Saint Joseph Hospital, Jerusalem, PSE.

出版信息

Cureus. 2024 Nov 8;16(11):e73275. doi: 10.7759/cureus.73275. eCollection 2024 Nov.

Abstract

Thyrotoxic periodic paralysis (TPP) is a rare complication primarily associated with thyrotoxicosis, particularly in individuals with Graves' disease. While more common in males aged 20 to 40, it can occur across all ethnic backgrounds. It is the most common type of acquired periodic paralysis. The condition is triggered by factors like exercise, stress, diet, and certain medications. The diagnosis is confirmed by severe hypokalemia and elevated thyroid hormones in the presence of acute flaccid paralysis. Immediate treatment involves correcting hypokalemia, while long-term management focuses on normalizing thyroid levels. In this article, we will report a case of a 30-year-old Middle Eastern man who presented to the emergency room with severe muscle weakness following extensive exertion and a high-carbohydrate diet. Physical examination revealed motor weakness in all limbs, particularly his lower limbs. Initial tests showed marked hypokalemia and biochemical thyrotoxicosis with suppressed thyroid-stimulating hormone (TSH) and elevated free triiodothyronine (T3) and free thyroxine (T4). An electrocardiogram (ECG) indicated signs of severe hypokalemia with an atrioventricular (AV) block. After he was diagnosed with TPP, the patient received oral and intravenous potassium infusions and was started on anti-thyroid medications, most importantly beta (β)-blockers. Following acute treatment, his potassium levels normalized, and he regained full muscle function. Ultimately, he was maintained on anti-thyroid medications at discharge to maintain an euthyroid state in order to prevent future recurrences of symptoms. Consequently, in patients presenting with acute flaccid paralysis, potassium level, and thyroid function should be investigated in order to promptly diagnose complications of thyrotoxicosis and to start an early appropriate combined therapy. The early and rapid management of TPP can prevent serious cardiopulmonary complications.

摘要

甲状腺毒症性周期性瘫痪(TPP)是一种罕见的并发症,主要与甲状腺毒症相关,尤其是在患有格雷夫斯病的个体中。虽然在20至40岁的男性中更为常见,但它可发生于所有种族背景的人群。它是获得性周期性瘫痪最常见的类型。该病症由运动、压力、饮食和某些药物等因素引发。在急性弛缓性麻痹的情况下,通过严重低钾血症和甲状腺激素升高来确诊。立即治疗包括纠正低钾血症,而长期管理则侧重于使甲状腺水平正常化。在本文中,我们将报告一例30岁的中东男性病例,该患者在剧烈运动和高碳水化合物饮食后出现严重肌肉无力,前往急诊室就诊。体格检查发现四肢均有运动无力,尤其是下肢。初步检查显示明显的低钾血症和生化性甲状腺毒症,促甲状腺激素(TSH)受抑制,游离三碘甲状腺原氨酸(T3)和游离甲状腺素(T4)升高。心电图(ECG)显示严重低钾血症伴有房室(AV)传导阻滞的迹象。在被诊断为TPP后,患者接受了口服和静脉补钾,并开始服用抗甲状腺药物,最重要的是β受体阻滞剂。经过急性治疗后,他的钾水平恢复正常,肌肉功能完全恢复。最终,他出院时继续服用抗甲状腺药物以维持甲状腺功能正常状态,以防止症状未来复发。因此,对于出现急性弛缓性麻痹的患者,应调查钾水平和甲状腺功能,以便及时诊断甲状腺毒症的并发症并尽早开始适当的联合治疗。TPP的早期快速管理可预防严重的心肺并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82be/11625411/f04f303d7611/cureus-0016-00000073275-i01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验